Old Web
English
Sign In
Acemap
>
authorDetail
>
A.T. van dePloeg
A.T. van dePloeg
Enzyme replacement therapy
Internal medicine
Medicine
Endocrinology
Vital capacity
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Respiratory function during enzyme replacement therapy in late-onset Pompe disease: longitudinal course, prognostic
2020
D. W. Stockton
P. Kishnani
A.T. van dePloeg
J. Llerena
M. Boentert
Mark Roberts
B Byrne
R Araújo
S.S. Maruti
N Thibault
K. Verhulst
K.I. Berger
Show All
Source
Cite
Save
Citations (0)
The ACE I/D polymorphism does not explain heterogeneity of natural course and response to enzyme replacement therapy in Pompe disease
2018
PLOS ONE
Esther Kuperus
J.C. van deMeijden
S.L.M. In’t Groen
Kroos
M. Hoogeveen-Westerveld
Dimitris Rizopoulos
M.Y. Nino Martinez
Michelle E. Kruijshaar
P.A. vanDoorn
N.A.M.E. van deBeek
A.T. van dePloeg
W. Pijnappel
Show All
Source
Cite
Save
Citations (5)
Glycogenosis type II : a study on clinical heterogeneity and enzyme replacement therapy
1989
A.T. van dePloeg
Show All
Source
Cite
Save
Citations (0)
1